Lanxess Acquires Asian Biocide Specialist PCTS

The German specialty chemicals group Lanxess has acquired Singapore-based PCTS Specialty Chemicals for an undisclosed amount. The transaction closes with immediate effect.

PCTS specializes in biocides for environmentally friendly water-based paints that meet stringent health and safety, as well as environmental standards. Biocides prevent the deterioration and discoloring of the paints caused by microorganisms.

PCTS employs about 20 people at modern production and laboratory facilities close to Lanxess Singapore headquarters. PCTS recorded sales in the single-digit million euro range in 2012, with 60% of it being generated in China. The company was majority owned by NIPSEA Technologies.

PCTS will be integrated into the Lanxess business unit Material Protection Products (MPP), which belongs to the company's Performance Chemicals segment. The PCTS facility will also become the new Asia-Pacific headquarters of MPP. The business unit acquired the U.S.-based biocide company Verichem and the material protection activities of Switzerland's Syngenta in 2011.

Lanxess has been present in Singapore since 2004 and is the home to about 380 employees. Singapore is also the global headquarters to the Butyl Rubber business unit, which began the commissioning phase of its new plant on Jurong Island in the first quarter. The plant is expected to start commercial production in the third quarter of 2013. In addition, the Performance Butadiene Rubbers business unit broke ground last year for a Nd-PBR plant on Jurong Island. Ian Wood is the company's country representative in Singapore.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.